Caribou Biosciences, Inc. (CRBU)
1.97
+0.06
(+3.14%)
USD |
NASDAQ |
Mar 19, 16:00
1.98
+0.01
(+0.51%)
After-Hours: 20:00
Caribou Biosciences Total Liabilities (Quarterly) : 57.46M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| EyePoint Plc | 57.88M |
| SELLAS Life Sciences Group, Inc. | 5.925M |
| GT Biopharma, Inc. | 2.319M |
| Aclaris Therapeutics, Inc. | 57.38M |
| CytomX Therapeutics, Inc. | 53.49M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 179.63M |
| Shareholders Equity (Quarterly) | 122.18M |
| Debt to Equity Ratio | 0.2229 |
| Current Ratio | 5.715 |
| Net Debt Paydown Yield | -0.08% |